D360

Serial Number 99174022
Registration 8066950
700

Registration Progress

Application Filed
May 7, 2025
Under Examination
Approved for Publication
Oct 28, 2025
Published for Opposition
Oct 28, 2025
Registered
Dec 16, 2025

Trademark Image

D360

Basic Information

Serial Number
99174022
Registration Number
8066950
Filing Date
May 7, 2025
Registration Date
December 16, 2025
Published for Opposition
October 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 16, 2025
Registration
Registered
Classes
009 042

Rights Holder

Certara USA, Inc.

03
Address
4 Radnor Corporate Center, Suite 350
Radnor, PA 19087

Ownership History

Certara USA, Inc.

Original Applicant
03
Radnor, PA

Certara USA, Inc.

Owner at Publication
03
Radnor, PA

Certara USA, Inc.

Original Registrant
03
Radnor, PA

Legal Representation

Attorney
Carrie Webb Olson

USPTO Deadlines

Next Deadline
2156 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251216)
Due Date
December 16, 2031
Grace Period Ends
June 16, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Dec 16, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 16, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 24, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 7, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 7, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable computer programs, namely, computer programs for use in performing chemical and biochemical computations and database searching and creating related analytical and graphic representations of chemical compounds and associated data, in identifying new compounds and drug lead candidates in the field of molecular scientific research, and in drug discovery research and chemical informatics and bio-informatics; Downloadable computer programs, namely, computer programs for use in product development, data analysis, and document, database, and project management in the field of pharmaceuticals, pharmacometrics and drug research, and planning, conducting, and analyzing the results of clinical drug trials and studies; Downloadable computer software to assist with product development, data analysis, and document, database, and project management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research
First Use Anywhere: 20100100
First Use in Commerce: 20100100
Class 042
Informatics services, namely, hosting computer platforms and portals on the internet for others, in particular for the capture and management of scientific data, namely, clinical data, pre-clinical and clinical trials, and logistics management; Software as a service (SAAS) services featuring software for data integration; Providing online non-downloadable software for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research
First Use Anywhere: 20100100
First Use in Commerce: 20100100

Additional Information

Pseudo Mark
D THREE SIX ZERO
Pseudo Mark
D THREE HUNDRED SIXTY
Pseudo Mark
D THREE SIXTY

Classification

International Classes
009 042